Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Nov 29:4:39.
doi: 10.1186/s40795-018-0247-6. eCollection 2018.

Comparison of two forms of daily preventive zinc supplementation versus therapeutic zinc supplementation for diarrhea on young children's physical growth and risk of infection: study design and rationale for a randomized controlled trial

K Ryan Wessells  1 , Kenneth H Brown  1   2 , Sengchanh Kounnavong  3 , Maxwell A Barffour  1 , Guy-Marino Hinnouho  1 , Somphou Sayasone  3 , Charles B Stephensen  4 , Kethmany Ratsavong  3 , Charles P Larson  5 , Charles D Arnold  1 , Kimberly B Harding  6 , Gregory A Reinhart  7 , Ganjana Lertmemongkolchai  8 , Supan Fucharoen  8 , Robin M Bernstein  9 , Sonja Y Hess  1
Affiliations

Comparison of two forms of daily preventive zinc supplementation versus therapeutic zinc supplementation for diarrhea on young children's physical growth and risk of infection: study design and rationale for a randomized controlled trial

K Ryan Wessells et al. BMC Nutr. .

Abstract

Background: Zinc is an essential nutrient that is required for children's normal growth and resistance to infections, including diarrhea and pneumonia, two major causes of child mortality. Daily or weekly preventive zinc supplementation has been shown to improve growth and reduce the risk of infection, while therapeutic zinc supplementation for 10-14 days is recommended for the treatment of diarrhea. The overall objective of the present study is to compare several regimens for delivering zinc to young children, both for the prevention of zinc deficiency and the treatment of diarrhea.

Methods: The present study is a community-based, randomized controlled trial in the Lao People's Democratic Republic (PDR). Three thousand, four hundred children 6-23 months of age will be randomized to one of four intervention groups (daily preventive zinc dispersible tablet, daily preventive multiple micronutrient powder, therapeutic zinc dispersible tablet for diarrhea, or placebo control); interventions will be delivered for 9 months and outcomes measured at pre-determined intervals. Primary outcomes include physical growth (length and weight), diarrhea incidence, hemoglobin and micronutrient status, and innate and adaptive immune function. Secondary outcomes include mid-upper-arm circumference, neuro-behavioral development, hair cortisol concentrations, markers of intestinal inflammation and parasite burden. Incidence of adverse events and the modifying effects of inherited hemoglobin disorders and iron status on the response to the intervention will also be examined. We will estimate unadjusted effects and effects adjusted for selected baseline covariates using ANCOVA.

Discussion: Many countries are now rolling out large-scale programs to include therapeutic zinc supplementation in the treatment of childhood diarrhea, but few have established programs demonstrated to be effective in the prevention of zinc deficiency. This study will address how best to deliver supplemental zinc to prevent zinc deficiency and reduce the severity of diarrhea-related health complications.

Trial registration: Trial registration identifier (NCT02428647) ; Date of registration: April 29, 2015.

Keywords: Diarrhea; Growth; Home-fortification; Micronutrient; Preventive; Supplementation; Therapeutic; Zinc.

PubMed Disclaimer

Conflict of interest statement

Competing interestsKBH is an employee of Nutrition International, formerly the Micronutrient Initiative and GAR was an employee of the Mathile Institute for the Advancement of Human Nutrition at the time of the initial proposal writing. KHB works for the Bill & Melinda Gates Foundation, which provided part of the financial support. The spouse of SYH works for the Bill & Melinda Gates Foundation. KRW, SK, MAB, GMH, SS, KR, CBS, CPL, CDA, GL, SF and RMB declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Enrollment and baseline assessments
Fig. 2
Fig. 2
Summary of sub-samples among entire study cohort
Fig. 3
Fig. 3
Flow chart of blood collection and analysis
See this image and copyright information in PMC

References

    1. The Zinc Investigators’ Collaborative Group. Bhutta ZA, Black RE, et al. Prevention of diarrhea and pneumonia by zinc supplementation in children in developing countries: pooled analysis of randomized controlled trials. J Pediatr. 1999;135:689–697. doi: 10.1016/S0022-3476(99)70086-7. - DOI - PubMed
    1. Brown KH, Peerson JM, Baker SK, et al. Preventive zinc supplementation among infants, preschoolers, and older prepubertal children. Food Nutr Bull. 2009;30(Suppl 1):S12–S40. doi: 10.1177/15648265090301S103. - DOI - PubMed
    1. Mayo-Wilson E, Junior JA, Imdad A, et al. Zinc supplementation for preventing mortality, morbidity, and growth failure in children aged 6 months to 12 years of age. Cochrane Database Syst Rev. 2014:CD009384. - PubMed
    1. Roth DE, Richard SA, Black RE. Zinc supplementation for the prevention of acute lower respiratory infection in children in developing countries: meta-analysis and meta-regression of randomized trials. Int J Epidemiol. 2010;39:795–808. doi: 10.1093/ije/dyp391. - DOI - PubMed
    1. Sazawal S, Black RE, Menon VP, et al. Zinc supplementation in infants born small for gestational age reduces mortality: a prospective, randomized, controlled trial. Pediatrics. 2001;108:1280–1286. doi: 10.1542/peds.108.6.1280. - DOI - PubMed

Associated data